EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitSystematische ÜbersichtOpen Access · CC BY 4.0

Immunotherapy for Head and Neck Cutaneous Squamous Cell Carcinoma with Perineural Spread: A Systematic Review

Jai Paris iD, James Tsimiklis iD, Ayushi Agarwal iD, Jessica Y Tong iD, Dinesh Selva

Head & Neck · 29.10.2026

DOI: 10.1002/hed.70533 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Head & Neck, online erschienen am 29.10.2026. Verfasst von Jai Paris und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, Australia. Die Arbeit nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Immunotherapy is increasingly used for head and neck cutaneous squamous cell carcinoma (cSCC) with perineural spread (PNS), though outcomes remain poorly defined.

Methods

A systematic review was conducted according to PRISMA and MOOSE guidelines. Studies reporting immunotherapy in cSCC with clinical or radiologic cranial nerve PNS were included. Data on demographics, nerve involvement, treatment, response, and outcomes were extracted.

Results

Twenty‐three studies (150 patients) were included. Median age was 72.5 years; 78.5% were male. PNS most commonly involved CNV (83.3%) and CNVII (31.7%). Immunotherapy was primarily cemiplimab (75.2%) and pembrolizumab (19.7%). Disease control was achieved in 87.3% (complete response: 38.7%, partial response: 42.0%). Functional nerve recovery was reported in 26/64 patients with evaluable outcomes (40.6%), equivalent to 17.3% of the total cohort. Median follow‐up was 16 months, with 82.3% alive. Adverse events occurred in 28%, with serious toxicity rare.

Conclusions

The available evidence demonstrates that immunotherapy can achieve disease control in cSCC with PNS and that established cranial nerve dysfunction may recover in some patients. Prospective studies with standardized oncological and functional outcomes are needed to better define treatment efficacy and establish the role of immunotherapy within current treatment paradigms.

Schlagwörter

Stichwörter der Autor:innen

Cemiplimabcranial nerve recoverycutaneous squamous cell carcinomaperineural spreadPD‐1 inhibitor

Autor:innen und Institutionen

  • Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, Australia.
  • Discipline of Ophthalmology and Vision Sciences, University of Adelaide, Adelaide, Australia.
  • South Australian Institute of Ophthalmology, Royal Adelaide Hospital, Adelaide, Australia.
  • Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.

ORCID-Profile: Jai Paris, James Tsimiklis, Ayushi Agarwal, Jessica Y Tong

Zitieren

APA

Paris, J., Tsimiklis, J., Agarwal, A., Tong, J. Y., & Selva, D. (2026). Immunotherapy for Head and Neck Cutaneous Squamous Cell Carcinoma with Perineural Spread: A Systematic Review. Head & Neck. https://doi.org/10.1002/hed.70533

Vancouver

Paris J, Tsimiklis J, Agarwal A, Tong JY, Selva D. Immunotherapy for Head and Neck Cutaneous Squamous Cell Carcinoma with Perineural Spread: A Systematic Review. Head & Neck. 2026. doi:10.1002/hed.70533

BibTeX
@article{Paris2026,
  author = {Paris, Jai and Tsimiklis, James and Agarwal, Ayushi and Tong, Jessica Y and Selva, Dinesh},
  title = {Immunotherapy for Head and Neck Cutaneous Squamous Cell Carcinoma with Perineural Spread: A Systematic Review},
  journal = {Head & Neck},
  year = {2026},
  doi = {10.1002/hed.70533}
}
Kostenlos starten →